Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05403736 · ClinicalTrials.gov registry record · NA
Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial
A NA study of Cancer, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05403736: Completed NA study of Cancer, sponsored by Cedars-Sinai Medical Center.
NCT05403736 is a NA study of Cancer that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 20 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05403736, a NA study of Cancer, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine adherence to cardio-oncology consultation.
Primary Outcome
Adherence is defined as 70% of the participants completing the cardio-oncology consultation visit prior to or during radiotherapy.
Conditions Studied
Interventions
- OTHER Cardiac Aggressive Risk MitigAtion Plan
Study Locations (1)
California
- Cancer Clinical Trials Office - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-10-07 |
| Est. Completion | 2023-06-16 |
| Phase | NA |
What the finished NCT05403736 record still lists
NCT05403736 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Aggressive Risk MitigAtion Plan is the first listed.
NCT05403736 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05403736 about?
NCT05403736 is a clinical study titled "Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial". The purpose of this study is to examine adherence to cardio-oncology consultation.
What is the current status of trial NCT05403736?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-10-07. Estimated completion is 2023-06-16.
What conditions does trial NCT05403736 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT05403736?
The interventions under investigation include: Cardiac Aggressive Risk MitigAtion Plan (OTHER).
Who is sponsoring clinical trial NCT05403736?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05403736 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05403736's enrollment target sits among peer trials
20 561st of 615 higher than 47 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI